Dirk Bredenbroker
Zurich, ZH, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Miquelianin and spiraeoside from Filipendula ulmaria mitigate α-synuclein accumulation in C.elegans and reduce the expression of neuroinflammatory cytokines in human microglia.
Journal: Frontiers in pharmacology
Published: October 07, 2025
Roflumilast for asthma: Efficacy findings in non-placebo-controlled comparator and dosing studies.
Journal: Pulmonary pharmacology & therapeutics
Published: July 24, 2015
Roflumilast for asthma: Efficacy findings in placebo-controlled studies.
Journal: Pulmonary pharmacology & therapeutics
Published: July 24, 2015
Roflumilast for asthma: Efficacy findings in mechanism of action studies.
Journal: Pulmonary pharmacology & therapeutics
Published: July 24, 2015
Roflumilast for asthma: Safety findings from a pooled analysis of ten clinical studies.
Journal: Pulmonary pharmacology & therapeutics
Published: July 24, 2015
Roflumilast and dyspnea in patients with moderate to very severe chronic obstructive pulmonary disease: a pooled analysis of four clinical trials.
Journal: International journal of chronic obstructive pulmonary disease
Published: July 15, 2014
Cardiovascular safety in patients receiving roflumilast for the treatment of COPD.
Journal: Chest
Published: February 16, 2013
Efficacy of roflumilast in the COPD frequent exacerbator phenotype.
Journal: Chest
Published: November 03, 2012
Effect of the phosphodiesterase 4 inhibitor roflumilast on glucose metabolism in patients with treatment-naive, newly diagnosed type 2 diabetes mellitus.
Journal: The Journal of clinical endocrinology and metabolism
Published: June 23, 2012
Physiological effects of roflumilast at rest and during exercise in COPD.
Journal: The European respiratory journal
Published: October 04, 2011
Showing 1-11 of 11
Last Updated: 09/26/2026